Behavior of 10 patients with FG syndrome (Opitz-Kaveggia syndrome) and the p.R961W mutation in the MED12 gene
- PMID: 18973276
- PMCID: PMC3092600
- DOI: 10.1002/ajmg.a.32553
Behavior of 10 patients with FG syndrome (Opitz-Kaveggia syndrome) and the p.R961W mutation in the MED12 gene
Abstract
Opitz and Kaveggia [Opitz and Kaveggia (1974); Z Kinderheilk 117:1-18] reported on a family of five affected males with distinctive facial appearance, mental retardation, macrocephaly, imperforate anus and hypotonia. Risheg et al. [Risheg et al. (2007); Nat Genet 39:451-453] identified an identical mutation (p.R961W) in MED12 in six families with Opitz-Kaveggia syndrome, including a surviving affected man from the family reported in 1974. The previously defined behavior phenotype of hyperactivity, affability, and excessive talkativeness is very frequent in young boys with this mutation, along with socially oriented, attention-seeking behaviors. We present case studies of two older males with FG syndrome and the p.R961W mutation to illustrate how their behavior changes with age. We also characterize the behavior of eight additional individuals with FG syndrome and this recurrent mutation in MED12 using the Vineland Adaptive Behavior Scales 2nd edition, the Reiss Profile of Fundamental Goals and Motivation Sensitivities, and the Achenbach Child Behavior Checklist. Males with this MED12 mutation had deficits in communication skills compared to their socialization and daily living skills. In addition, they were at increased risk for maladaptive behavior, with a propensity towards aggression, anxiety, and inattention. Based on the behavior phenotype in 10 males with this recurrent MED12 mutation, we offer specific recommendations and interventional strategies. Our findings reinforce the importance of testing for the p.R961W MED12 mutation in males who are suspected of having developmental and behavioral problems with a clinical phenotype that is consistent with FG syndrome.
Copyright (c) 2008 Wiley-Liss, Inc.
Figures


References
-
- Achenbach TM. Manual for the child behavior checklist/4–18 and 1991 profile. Burlington, VT: University of Vermont Department of Psychiatry; 1991.
-
- Berry-Kravis E, Potanos K. Psychopharmacology in fragile X syndrome--present and future. Mental Retardation and Developmental Disabilities Research Reviews. 2004;10:42–48. - PubMed
-
- Briault S, Hill R, Shrimpton A, Zhu D, Till M, Ronce N, Margaritte-Jeannin P, Baraitser M, Middleton-Price H, Malcolm S, Thompson E, Hoo J, Wilson G, Romano C, Guichet A, Pembrey M, Fontes M, Poustka A, Moraine C. A gene for FG syndrome maps in the Xq12-q21.31 region. Am J Med Genet. 1997;73:87–90. - PubMed
-
- Briault S, Odent S, Lucas J, Le Merrer M, Turleau C, Munnich A, Moraine C. Paracentric inversion of the X chromosome [inv(X)(q12q28)] in familial FG syndrome. A. J Med Genet. 1999;86:112–114. - PubMed
-
- Briault S, Villard L, Rogner U, Coy J, Odent S, Lucas J, Passage E, Zhu D, Shrimpton A, Pembrey M, Till M, Guichet A, Dessay S, Fontes M, Poustka A, Moraine C. Mapping of X chromosome inversion breakpoints [inv(X)(q11q28)] associated with FG syndrome: a second FG locus [FGS2]? Am J Med Genet. 2000;95:178–181. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- M01-RR00425/RR/NCRR NIH HHS/United States
- KL2 TR000455/TR/NCATS NIH HHS/United States
- P01 HD022657/HD/NICHD NIH HHS/United States
- K12 RR025009,/RR/NCRR NIH HHS/United States
- M01 RR000425/RR/NCRR NIH HHS/United States
- L32 MD000625/MD/NIMHD NIH HHS/United States
- HD262020/HD/NICHD NIH HHS/United States
- HD22657/HD/NICHD NIH HHS/United States
- KL2 RR025009/RR/NCRR NIH HHS/United States
- T32 GM008243/GM/NIGMS NIH HHS/United States
- UL1 TR000454/TR/NCATS NIH HHS/United States
- R01 HD026202/HD/NICHD NIH HHS/United States
- 5-T32-GM08243/GM/NIGMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical